HIV 1 News and Research

RSS

Study reveals protective potential of new class of antibodies against HIV-1 infection

A group of scientists at Texas Biomedical Research Institute have zeroed in on a new defense against HIV-1, the virus that causes AIDS. Led by Ruth Ruprecht, M.D., Ph.D., the team used an animal model to show for the first time that an antibody called Immunoglobulin M was effective in preventing infection after mucosal AIDS virus exposure.

24 Jul 2018

Researchers report first randomized trial results of 'kick and kill' approach to treat HIV

Researchers have reported the results of the first randomized clinical trial to test a novel strategy involving waking up and then killing the 'sleeping' HIV that is hiding in the body using an experimental approach known as 'kick and kill'.

24 Jul 2018

Scientists find abnormal gene copying in fruit fly models of tauopathies

It sounds like science fiction: Nefarious genes clone themselves and settle their rogue copies in distant outposts of the galaxy (namely, our DNA), causing disease.

24 Jul 2018

Study reports data on dementia prevalence in sexual minority older adults

The first dementia prevalence data from a large population of lesbian, gay and bisexual older adults was reported today at the 2018 Alzheimer's Association International Conference in Chicago.

23 Jul 2018

Study: People with HIV twice as likely to suffer from heart disease

People infected with HIV are twice as likely to suffer from heart disease, research has found.

18 Jul 2018

Parental incarceration affects health behaviors of children in adulthood

A new study published in Pediatrics found that young adults who had a parent incarcerated during their childhood are more likely to skip needed healthcare, smoke cigarettes, engage in risky sexual behaviors, and abuse alcohol, prescription and illicit drugs.

17 Jul 2018

Animal studies reveal brain changes responsible for appetite effects of cannabis

New research on how cannabis use alters eating behavior could lead to treatments for appetite loss in chronic illness, according to experts at Washington State University.

17 Jul 2018

CRISPR/Cas9 gene editing can cause greater genetic damage than previously thought

Scientists at the Wellcome Sanger Institute have discovered that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought. These results create safety implications for gene therapies using CRISPR/Cas9 in the future as the unexpected damage could lead to dangerous changes in some cells.

16 Jul 2018

California clinic screens asylum seekers for honesty

Dr. Nick Nelson walks through busy Highland Hospital to a sixth-floor exam room, where he sees patients from around the world who say they have fled torture and violence.

16 Jul 2018

Routine screening, treatment could help stem nationwide opioid epidemic

To help stem the nationwide opioid epidemic and related increases in HIV, hepatitis C and other infections, health care providers should routinely screen and treat patients for opioid abuse when they come to clinics and hospitals seeking other services.

16 Jul 2018

Imaging techniques may help assess immune system recovery in HIV patients

Findings from an animal study suggest that a non-invasive imaging technique could, with further development, become a useful tool to assess immune system recovery in people receiving treatment for HIV infection.

13 Jul 2018

Aeras announces publication of Phase 2 results of two TB vaccines

Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis (TB), today announced the publication of the full results from a Phase 2, randomized, controlled clinical trial of two TB vaccines-- the currently available BCG vaccine and an investigational vaccine, H4:IC31--in the New England Journal of Medicine (NEJM).

12 Jul 2018

New 3D model of 1918 H1 pandemic influenza virus could benefit VLP vaccine projects

Virus-like particles are protein-based structures that mimic viruses and bind to antibodies. Because VLPs are not infectious, they show considerable promise as vaccine platforms for many viral diseases, including influenza.

12 Jul 2018

Molecular insights of NagA enzyme could help combat TB

Research by a team led by Dr Elizabeth Fullam, has revealed new findings about an enzyme found in Mycobacterium tuberculosis the bacterium that causes TB.

12 Jul 2018

HIV-positive children in South Africa more likely to have developmental disabilities

HIV-positive children in South Africa are more likely to have developmental disabilities compared to children who are HIV negative, according to researchers at Columbia University's Mailman School of Public Health.

11 Jul 2018

Differences in mouth bacteria of HIV-infected youth may increase risk of cavities

A team of scientists from The Forsyth Institute, a global leader in oral health research, in collaboration with the NIH-funded Pediatric HIV/AIDS Cohort Study, has published the results of a new study indicating that differences in the mouth bacteria of youth born with HIV may increase their risk of cavities.

11 Jul 2018

Researchers highlight the need for wider access to HIV prevention drugs

Despite highly effective anti-HIV pharmaceuticals having been used worldwide for almost a decade, HIV has not been conquered.

11 Jul 2018

Male couples experience as much domestic violence as heterosexual couples

Nearly half of all men in a new study about intimate partner violence in male couples report being victims of abuse.

10 Jul 2018

Preventative HIV vaccines induce robust, comparable immune responses in humans and monkeys

More than three decades after the identification of the human immunodeficiency virus, scientists are still working to develop a preventative vaccine that could finally put an end to the epidemic for which there are nearly two million new infections each year.

9 Jul 2018

Step towards an HIV/AIDS vaccine

There has been a four decades long challenge to develop a vaccine against the deadly HIV virus that causes AIDS. Last Saturday the research bore fruit when a team of scientists announced that a trial drug has shown immune response in humans and also protected laboratory monkeys from HIV infection.

9 Jul 2018

HIV 1 News and Research

Study reveals protective potential of new class of antibodies against HIV-1 infection

Researchers report first randomized trial results of 'kick and kill' approach to treat HIV

Scientists find abnormal gene copying in fruit fly models of tauopathies

Study reports data on dementia prevalence in sexual minority older adults

Study: People with HIV twice as likely to suffer from heart disease

Parental incarceration affects health behaviors of children in adulthood

Animal studies reveal brain changes responsible for appetite effects of cannabis

CRISPR/Cas9 gene editing can cause greater genetic damage than previously thought

California clinic screens asylum seekers for honesty

Routine screening, treatment could help stem nationwide opioid epidemic

Imaging techniques may help assess immune system recovery in HIV patients

Aeras announces publication of Phase 2 results of two TB vaccines

New 3D model of 1918 H1 pandemic influenza virus could benefit VLP vaccine projects

Molecular insights of NagA enzyme could help combat TB

HIV-positive children in South Africa more likely to have developmental disabilities

Differences in mouth bacteria of HIV-infected youth may increase risk of cavities

Researchers highlight the need for wider access to HIV prevention drugs

Male couples experience as much domestic violence as heterosexual couples

Preventative HIV vaccines induce robust, comparable immune responses in humans and monkeys

Step towards an HIV/AIDS vaccine

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News